Inhalation Drug Delivery Solutions
-
Organ On A Chip: Advancing New Approach Methodologies
2/18/2025
Explore new approach methodologies, integrating in vitro and computational models to improve toxicology testing, and drug development, enhancing accuracy, efficiency, and human relevance.
-
Blow/Fill/Seal Packaging Systems
7/9/2020
Weiler Engineering’s ASEP-TECH® Blow/Fill/Seal machines are ideal for processing temperature sensitive products such as biological and protein-based materials – providing a level of enhanced sterility assurance.
-
Medical Device Technical Due Diligence
6/4/2024
By partnering with Battelle, your organization can reduce risks and save on investment costs, leading to more successful and sustainable outcomes.
-
Designed For Inhalation: Pulmonary And Nasal Delivery
Our newly expanded in-house capabilities span clinical and commercial scale manufacturing for DPIs, unit-dose, bi-dose and preserved multi-dose nasal sprays.
-
Pulmonary
2/27/2026
See key inhalation platforms and their advantages, showing how targeted delivery, formulation flexibility, and patient-friendly design support efficient development and stronger therapeutic outcomes.
-
Nasal Drug Delivery
2/2/2026
How integrated analytics, formulation, and manufacturing enable fast‑acting, noninvasive nasal therapies while helping teams align delivery needs, regulations, and performance goals.
-
NanoImprove The Performance Of Your Biologic Formulation
11/20/2025
Unlock superior performance for peptides and proteins using nanotechnology. Achieve high drug loads for subcutaneous delivery and stable, aerodynamic dry powders for deep-lung inhalation.
-
Battelle uLAB
3/21/2024
This comprehensive suite of services encompasses the entire spectrum of user research, starting from the conceptualization of study designs to meticulous data analysis and comprehensive reporting.
-
Pulmonary Drug Delivery
2/2/2026
Modern inhalation platforms, improved formulations, and greener propellants speed development and strengthen respiratory performance, with key factors guiding device choice and clinical readiness.
-
Pharmaceutical Development
4/24/2023
Developing an optimized formulation tailored to your API nanoparticles is critical to unlocking their full potential.